Invesco’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $340K | Buy |
79,929
+29,119
| +57% | +$124K | ﹤0.01% | 3321 |
|
2025
Q1 | $191K | Buy |
50,810
+34,362
| +209% | +$129K | ﹤0.01% | 3508 |
|
2024
Q4 | $95.9K | Buy |
16,448
+1,293
| +9% | +$7.54K | ﹤0.01% | 3614 |
|
2024
Q3 | $181K | Sell |
15,155
-327
| -2% | -$3.9K | ﹤0.01% | 3522 |
|
2024
Q2 | $168K | Buy |
15,482
+491
| +3% | +$5.31K | ﹤0.01% | 3657 |
|
2024
Q1 | $170K | Sell |
14,991
-10,809
| -42% | -$122K | ﹤0.01% | 3663 |
|
2023
Q4 | $362K | Sell |
25,800
-380,942
| -94% | -$5.34M | ﹤0.01% | 3364 |
|
2023
Q3 | $5.02M | Buy |
406,742
+68,725
| +20% | +$849K | ﹤0.01% | 2203 |
|
2023
Q2 | $3.05M | Buy |
+338,017
| New | +$3.05M | ﹤0.01% | 2476 |
|
2021
Q4 | – | Sell |
-8,263
| Closed | -$228K | – | 4047 |
|
2021
Q3 | $228K | Sell |
8,263
-241,314
| -97% | -$6.66M | ﹤0.01% | 3725 |
|
2021
Q2 | $6.98M | Buy |
249,577
+3,159
| +1% | +$88.4K | ﹤0.01% | 2272 |
|
2021
Q1 | $8.18M | Sell |
246,418
-283,582
| -54% | -$9.41M | ﹤0.01% | 2075 |
|
2020
Q4 | $25.5M | Buy |
+530,000
| New | +$25.5M | 0.01% | 1310 |
|